Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Rgenix treats first patient in Phase Ia/b cancer drug study

Rgenix intends to enrol around 60 patients for a Phase la/b study of RGX-202. Credit: Rgenix Inc.

  • Doctor

Go Top